MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
Frederik Barkhof(Netherlands Institute for Neuroscience), Massimo Filippi(Vita-Salute San Raffaele University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Ludwig Kappos(Novartis (Switzerland)), Franz Fazekas(Medical University of Graz), Marco Rovaris(San Raffaele University of Rome), Maria Pia Sormani(University of Genoa), Nicola De Stefano(University of Siena), David K. Li(University of British Columbia), John Petkau(National Multiple Sclerosis Society), Paul O’Connor, David H. Miller(National Hospital for Neurology and Neurosurgery), Ernst W. Radue(University Hospital of Basel), Jack H. Simon(University of Colorado Health), Chris H. Polman(Vrije Universiteit Amsterdam)
Cited by 76
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k